AOD9604 Powder For Bodybuilding CAS:221231-10-3

    Introduction to AOD9604 Powder

    AOD9604 (Advanced Obesity Drug 9604) is a synthetic peptide derived from the C-terminal fragment of human growth hormone (hGH). Developed in the 1990s by Australian researchers, it was initially designed to combat obesity by mimicking hGH's fat-burning properties without the adverse effects of full-length growth hormone. Over time, bodybuilders and athletes adopted AOD9604 for its purported ability to enhance fat loss, preserve lean muscle, and accelerate recovery. Unlike traditional hGH, AOD9604 operates through a unique mechanism that targets adipose tissue directly, making it a novel tool in bodybuilding.

    ●Molecular Structure: A 16-amino acid fragment (Tyr-hGH 177-191) with modifications to enhance stability and bioavailability.

    ●Mechanism of Action: Binds to beta-3 adrenergic receptors on adipocytes, triggering lipolysis (fat breakdown) and inhibiting lipogenesis (fat storage).

    ●Non-Hormonal: Does not interfere with insulin or IGF-1 pathways, reducing risks of metabolic disruption.

    ●Thermogenic Effect: Increases mitochondrial activity, boosting calorie expenditure.

    ●Rapid Absorption: Subcutaneous administration ensures quick entry into the bloodstream.

    3.1 Fat Loss and Cutting

    AOD9604 is prized during cutting phases for its ability to target stubborn fat deposits (e.g., abdominal, thigh) while sparing muscle mass. It enhances lipolysis, converting stored fat into free fatty acids for energy, which is critical when caloric intake is restricted.

    3.2 Muscle Preservation

    By suppressing cortisol (a catabolic hormone), AOD9604 helps maintain muscle tissue during calorie deficits. Users report less muscle wasting compared to traditional dieting or stimulant-based fat burners.

    3.3 Enhanced Recovery

    AOD9604 upregulates collagen synthesis and cellular repair mechanisms, reducing downtime between workouts. This is particularly beneficial for high-frequency training regimens.

    3.4 Synergy with SARMs and Peptides

    Stacked with compounds like MK-677 (a growth hormone secretagogue) or Cardarine (PPAR-delta agonist), AOD9604 amplifies fat oxidation and endurance. Unlike clenbuterol, it avoids cardiovascular strain.

    ●No Desensitization: Unlike beta-2 agonists (e.g., clenbuterol), AOD9604 does not downregulate receptors with prolonged use.

    ●Minimal Side Effects: Lacks the water retention, joint pain, or insulin resistance associated with hGH.

    ●Legal Status: Not classified as a controlled substance in many countries, making it accessible for research purposes.

    ●Non-Suppressive: Does not inhibit natural hormone production, eliminating the need for post-cycle therapy (PCT).

    ●Effective Dose: 300–600 mcg per day, split into 1–2 subcutaneous injections.

    ●Timing: Preferentially administered in the morning or pre-workout to align with natural cortisol rhythms.

    ●Cycle Length: 8–12 weeks, with no required off-period due to its non-hormonal nature.

    ●Reconstitution: Mixed with bacteriostatic water; stable for 2–3 weeks when refrigerated.

    ●Half-Life: ~30 minutes, necessitating daily dosing for sustained effects.

    ●Metabolism: Degraded by peptidases in the bloodstream, with metabolites excreted renally.

    ●Bioavailability: 95% via injection; oral use is ineffective due to gastric degradation.

    AOD9604 does not suppress the hypothalamic-pituitary-gonadal (HPG) axis, making traditional PCT (e.g., SERMs like tamoxifen) unnecessary. However, users combining it with androgenic compounds should follow standard PCT protocols for those substances.

    ●Common: Mild injection-site reactions (redness, itching).

    ●Rare: Headaches or transient increases in blood glucose (manageable with diet).

    ●Contraindications: Avoid during pregnancy or with pre-existing metabolic disorders.

    Recent studies (2023) highlight AOD9604's potential in treating metabolic syndrome and osteoarthritis, expanding its appeal beyond bodybuilding. Trials using nanoliposome-encapsulated AOD9604 show promise for oral bioavailability, though this remains experimental.

    ●Stacking: Pair with berberine to enhance insulin sensitivity and AMPK activation.

    ●Diet: Prioritize omega-3 fatty acids to upregulate beta-3 receptor expression.

    ●Training: Incorporate fasted cardio to synergize with AOD9604's lipolytic effects.

    ●Myth: AOD9604 causes hyperplasia (abnormal cell growth).
    Reality: It lacks the IGF-1 activity required for hyperplasia, focusing solely on hypertrophy.

    ●Myth: It's a steroid.
    Reality: A peptide with no androgenic or estrogenic activity.

    While legal in most regions, competitive athletes should verify AOD9604's status with organizations like WADA. Its absence from many banned-substance lists reflects its relatively recent adoption.

Trade names	Fragment 177-191; AOD 9604 acetate; peptides AOD9604; Peptide HGH 176-191; polypeptide AOD 9604; HGH frag 176-191 Oxidized
CAS	221231-10-3
Molar mass	1815.1
MF	C78H123N23O23S2
Purity	Above 98%
Apprarance	White crystalline powder

 

 

Any needs, please contact us

Email: Jasonraws106@gmail.com

WhatsApp: +86-15572565525
Telegram: +86-19128233885

   

                                

 

    AOD9604 represents a paradigm shift in bodybuilding pharmacology, offering targeted fat loss and recovery with minimal risk. As research evolves, its applications may expand into longevity and regenerative medicine. For now, it remains a cutting-edge tool for physique enhancement, distinct from traditional anabolics or stimulants.

Hot Tags: aod9604 powder for bodybuilding cas:221231-10-3, China aod9604 powder for bodybuilding cas:221231-10-3 manufacturers, suppliers, factory